Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
ESC Heart Failure
|
September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI
David Erlinge, Stefan James, John Deanfield, et al.
NEJM Evidence
|
February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
Stefan James, David Erlinge, Robert F Storey, et al.
BMJ Open
|
January 13, 2022
Efficacy and cost-effectiveness of an online mindfulness program (MindOnLine) to reduce fear of recurrence among people with cancer: study protocol for a randomised controlled trial
Patricia M Livingston, Lahiru Russell, Liliana Orellana, et al.
Heart (British Cardiac Society)
|
September 4, 2025
Benefit-risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trial
Marc-André d'Entremont, Sanjit S Jolly, Faisal Alharthi, et al.
JACC. Cardiooncology
|
October 31, 2024
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial
David Austin, Rebecca H Maier, Nasima Akhter, et al.
The New England Journal of Medicine
|
September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial Infarction
Vijay Kunadian, Helen Mossop, Carol Shields, et al.
Journal of Clinical Medicine
|
September 9, 2023
Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry
Wout W A van den Broek, Marieke E Gimbel, Dean R P P Chan Pin Yin, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
ESC Heart Failure
|
September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI
David Erlinge, Stefan James, John Deanfield, et al.
NEJM Evidence
|
February 6, 2024
Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure
Stefan James, David Erlinge, Robert F Storey, et al.
BMJ Open
|
January 13, 2022
Efficacy and cost-effectiveness of an online mindfulness program (MindOnLine) to reduce fear of recurrence among people with cancer: study protocol for a randomised controlled trial
Patricia M Livingston, Lahiru Russell, Liliana Orellana, et al.
Heart (British Cardiac Society)
|
September 4, 2025
Benefit-risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trial
Marc-André d'Entremont, Sanjit S Jolly, Faisal Alharthi, et al.
JACC. Cardiooncology
|
October 31, 2024
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial
David Austin, Rebecca H Maier, Nasima Akhter, et al.
The New England Journal of Medicine
|
September 3, 2024
Invasive Treatment Strategy for Older Patients with Myocardial Infarction
Vijay Kunadian, Helen Mossop, Carol Shields, et al.
Journal of Clinical Medicine
|
September 9, 2023
Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry
Wout W A van den Broek, Marieke E Gimbel, Dean R P P Chan Pin Yin, et al.
Page
of 14